HHS is requesting changes to prescribing information for testosterone therapy products following a review of new clinical data and scientific evidence, according to a press release from the agency. As Healio previously reported, the FDA convened a panel in December that discussed removing some contraindications for testosterone therapy as well as taking testosterone therapy off the list of

FDA is removing warning labels from testosterone replacement therapy, or TRT, as a key advancement of men's health.

HHS is requesting changes to prescribing information for testosterone therapy products following a review of new clinical data and scientific evidence, according to a press…

The US Department of Health and Human Services is requesting revisions to the labels on testosterone replacement therapies for men after reviewing new data and evidence on their…